Correlation Between Iradimed and SurModics
Can any of the company-specific risk be diversified away by investing in both Iradimed and SurModics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iradimed and SurModics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iradimed Co and SurModics, you can compare the effects of market volatilities on Iradimed and SurModics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iradimed with a short position of SurModics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iradimed and SurModics.
Diversification Opportunities for Iradimed and SurModics
Very weak diversification
The 3 months correlation between Iradimed and SurModics is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Iradimed Co and SurModics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SurModics and Iradimed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iradimed Co are associated (or correlated) with SurModics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SurModics has no effect on the direction of Iradimed i.e., Iradimed and SurModics go up and down completely randomly.
Pair Corralation between Iradimed and SurModics
Given the investment horizon of 90 days Iradimed Co is expected to generate 0.77 times more return on investment than SurModics. However, Iradimed Co is 1.29 times less risky than SurModics. It trades about -0.03 of its potential returns per unit of risk. SurModics is currently generating about -0.16 per unit of risk. If you would invest 5,492 in Iradimed Co on December 30, 2024 and sell it today you would lose (251.00) from holding Iradimed Co or give up 4.57% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Iradimed Co vs. SurModics
Performance |
Timeline |
Iradimed |
SurModics |
Iradimed and SurModics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iradimed and SurModics
The main advantage of trading using opposite Iradimed and SurModics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iradimed position performs unexpectedly, SurModics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SurModics will offset losses from the drop in SurModics' long position.Iradimed vs. Pulmonx Corp | Iradimed vs. Orthofix Medical | Iradimed vs. Neuropace | Iradimed vs. Integer Holdings Corp |
SurModics vs. LivaNova PLC | SurModics vs. Electromed | SurModics vs. Orthopediatrics Corp | SurModics vs. Neuropace |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |